Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02549573 · ClinicalTrials.gov registry record · Phase 4
Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN®
A Phase 4 study, sponsored by MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals.
- Terminated
- Registry status
- Phase 4
- Development phase
- 13
- Enrollment target
NCT02549573 is a Phase 4 study that was terminated before completion, run by MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals. The registered enrollment target is 13 participants.
The verdict
NCT02549573, a Phase 4 study, was terminated before completion, sponsored by MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 13 participants
- Enrollment target
Study Summary
To determine if PT intervention will be improved while in the "on" motor state vs. the "end-of-dose-off" motor state during the PT Intervention Visit in subjects with PD.
Interventions
- BEHAVIORAL Physical Therapy
- DRUG APOKYN
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2016-01 |
| Est. Completion | 2016-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02549573
The ClinicalTrials.gov registry entry for NCT02549573 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Physical Therapy is the first listed.
NCT02549573 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02549573 about?
NCT02549573 is a clinical study titled "Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN®". To determine if PT intervention will be improved while in the "on" motor state vs. the "end-of-dose-off" motor state during the PT Intervention Visit in subjects with PD.
What is the current status of trial NCT02549573?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 13 participants. The study started on 2016-01. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02549573?
The interventions under investigation include: Physical Therapy (BEHAVIORAL), APOKYN (DRUG).
Who is sponsoring clinical trial NCT02549573?
This trial is sponsored by MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.